Ajai Chari, MD, associate professor of medicine, Hematology and Medical Oncology, Mount Sinai Hospital, discusses the impact of CAR T-cell therapy in myeloma.
Ajai Chari, MD, PhD
Advertisement
Articles by Ajai Chari, MD, PhD
Advertisement
Latest Updated Articles
Dr. Chari on Impact of CAR T Cells in MyelomaPublished: November 16th 2018 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
2
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
3
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
4
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
5
